%0 Journal Article %T Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE %+ Service d'urologie [Mondor] %+ Institut Mondor de Recherche Biomédicale (IMRB) %+ CHU Pontchaillou [Rennes] %+ Laboratoire Traitement du Signal et de l'Image (LTSI) %A Ouzaid, Idir %A Bensalah, Karim %< avec comité de lecture %@ 0302-2838 %J European Urology %I Elsevier %V 68 %N 3 %P 542--543 %8 2015-09 %D 2015 %R 10.1016/j.eururo.2015.04.042 %M 26001611 %Z Life Sciences [q-bio]/BioengineeringJournal articles %X Referred to by Matteo Santoni, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Alberto Briganti, Francesco Montorsi, Rodolfo Montironi, Daniele Santini Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542–3 European Urology, Available online 1 October 2015 %G English %2 https://univ-rennes.hal.science/hal-01260239/document %2 https://univ-rennes.hal.science/hal-01260239/file/Results%20of%20the%20First%20Trial%20Assessing%20Adjuvant%20Tyrosine%20Kinase%20Inhibitors%20in%20Renal%20Cell%20Carcinoma%20Do%20Not%20reASSURE.pdf %L hal-01260239 %U https://univ-rennes.hal.science/hal-01260239 %~ INSERM %~ UNIV-RENNES1 %~ LTSI %~ APHP %~ IMRB %~ UPEC %~ HL %~ STATS-UR1 %~ UR1-HAL %~ UR1-MATH-STIC %~ TEST-UNIV-RENNES %~ TEST-UR-CSS %~ UNIV-RENNES %~ UR1-MATH-NUM %~ UR1-BIO-SA